ELI LILLY & Co is 182.2x more valuable than RHYTHM PHARMACEUTICALS, INC. by market capitalization ($1.070 T vs $5.87 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RYTM | LLY |
|---|---|---|
| Market cap | $5.87 B | $1.070 T |
| US-listed rank | #1281 | #10 |
| Revenue (latest FY) | $189.76M | $65.18B |
| Net income (latest FY) | -$196.54K | $20.64B |
| Net margin | -0.1% | 31.7% |
| P/E (trailing FY) | - | 51.8 |
| SEC filings | 799 | 989 |
ELI LILLY & Co is 182.2x more valuable than RHYTHM PHARMACEUTICALS, INC. by market capitalization ($1.070 T vs $5.87 B).
In their latest fiscal years, RHYTHM PHARMACEUTICALS, INC. reported $189.76M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: RHYTHM PHARMACEUTICALS, INC. and ELI LILLY & Co, or browse the full rankings.